CrossrefInfokarte
Dual, Postsynaptic 5-HT2B Antagonist and 5-HT1A Agonist Approach to the Treatment of METH/MDMA Addiction and Related Problems. Part 2. Proof of Concept.
Receptors & Clinical Investigation · 2014
DOI: 10.14800/rci.106 ↗Abstract
Kein Abstract verfügbar.
EUVIMED